Stefanie Chee, PA
Physician Assistant · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Stefanie Chee’s office at (650) 723-4000 to ask if they take your plan before you enroll.
California Medical Board record
Licence G60109 · Cancelled
Licence status: Cancelled · since 1987 · Duke University School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$2,785 in 2024
Medicaid paid $2,785 for 25 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 25 | $2,785 |
| 2024 | 25 | 1 | 13 | $2,785 |
| 2023 | 13 | 1 | 13 | $570 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 13 | $570 |
Drugs they prescribed that Part D paid
$1,450,771
Pharmacies billed $1,450,771 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
594 generic and 157 brand-name prescriptions · $1,450,771 in drug cost · 67 antibiotic prescriptions to 27 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jakafi | 91 | $835,125 | $9,177 |
| Rezurock | 17 | $327,799 | $19,282 |
| Prevymis | 20 | $158,424 | $7,921 |
| Atovaquone | 66 | $26,179 | $397 |
| Posaconazole | 37 | $6,970 | $188 |
See all 16 drugs
| Jakafi | 91 | $835,125 | $9,177 |
| Rezurock | 17 | $327,799 | $19,282 |
| Prevymis | 20 | $158,424 | $7,921 |
| Atovaquone | 66 | $26,179 | $397 |
| Posaconazole | 37 | $6,970 | $188 |
| Ursodiol | 47 | $3,516 | $75 |
| Tacrolimus | 36 | $2,231 | $62 |
| Acyclovir | 100 | $2,092 | $21 |
| Sirolimus | 14 | $1,718 | $123 |
| Deferasirox | 15 | $1,029 | $69 |
| Budesonide Dr | 13 | $974 | $75 |
| Dexamethasone | 35 | $880 | $25 |
| Triamcinolone Acetonide | 29 | $690 | $24 |
| Sulfamethoxazole-Trimethoprim | 56 | $425 | $8 |
| Prednisone | 35 | $350 | $10 |
| Potassium Chloride | 18 | $344 | $19 |
Year by year
| 2024 | 751 | 110 | None | 21% | $1,450,771 |
| 2023 | 497 | 84 | None | None | $765,699 |
| 2022 | 55 | 22 | None | None | $2,781 |
| 2020 | 11 | None | None | None | $14,753 |
| 2019 | 32 | 12 | None | None | $13,748 |
| 2018 | 43 | 12 | None | None | $13,706 |
| 2017 | 91 | 20 | None | None | $14,795 |
| 2016 | 32 | None | None | None | $3,156 |
| 2015 | 21 | 15 | None | None | $628 |
| 2014 | 39 | 19 | None | None | $1,320 |
| 2013 | 41 | 20 | None | None | $2,410 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Jakafi | 54 | $501,708 | $9,291 |
| Atovaquone | 31 | $10,470 | $338 |
| Posaconazole | 32 | $9,135 | $285 |
| Ursodiol | 37 | $2,548 | $69 |
| Tacrolimus | 28 | $2,027 | $72 |
| Dexamethasone | 41 | $857 | $21 |
| Deferasirox | 11 | $768 | $70 |
| Acyclovir | 25 | $617 | $25 |
| Ipol | 14 | $502 | $36 |
| Potassium Chloride | 12 | $373 | $31 |
| Prednisone | 30 | $361 | $12 |
| Triamcinolone Acetonide | 16 | $345 | $22 |
| Sulfamethoxazole-Trimethoprim | 30 | $215 | $7 |
| Gabapentin | 11 | $117 | $11 |
Money from drug and device companies
$22 in 2021
A payment is not proof that care is biased.
| Daiichi Sankyo | Enhertu | $22 | 1 payment
|
See the published payment
| Daiichi Sankyo | Meals · 2021-04-22 | Enhertu | $22 |
Professional record
- NPI
- 1548563695
- Licence
- CA 60109, NY 014531California G60109: Cancelled
- Group
- Stanford Health Care
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2010-12-13
- NPI last updated
- 2026-01-27
- NPI record certified
- 2026-01-27
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 520 N Main St Ste 120, Santa Ana, CA, 92701
This office lists an electronic records connection.